ALS patients’ tissues exhibit increased phosphorylation of MARK2. by Yu-Ning Lu (10291271)

“…<p>(<b>A</b>) Representative immunoblot analyses of PKCδ, MARK2-⁵⁹⁵T, and eIF2α in the spinal cord tissues from ALS patients and non-ALS controls, indicating that increased phosphorylation of PKCδ-⁵⁰⁵T, MARK2-⁵⁹⁵T, and eIF2α-⁵¹S is a general phenotype in patient tissues. …”

General procedure for the synthesis of the target compounds 11a,b,15a,b. by Ahmed A. Gaber (13302308)

Subjects:

Deletion of Hhp2 markedly increased Sre1 activity. by Hao Miao (1742044)

“…<p>Deletion of <i>hhp2</i>⁺ gene markedly increased Sre1 activity in the presence/absence of CLZ (2 μg/ml to 8 μg/ml) (A), TER (2 μg/ml to 8 μg/ml) (B) or CoCl₂ (0.08 mM to 0.32 mM) (C). …”

3D interactions between the ligand and the protein_DNA complex in the first (C1) and second (C2) clusters. by Ahmed A. Gaber (13302308)

Subjects:

Non-permissive chromatin marks increase in the surviving population after T cell stimulation. by Birgitta Lindqvist (8378349)

General procedures for the synthesis of the key compounds 7a, b, 9, and 10. by Ahmed A. Gaber (13302308)

Subjects:

Prevalence of infection with (A) hepatitis B virus or (B) hepatitis C virus hepatocellular carcinoma among Medicare Part D beneficiaries, 2007–2017. by Joy Jiang (5483006)

Subjects:

Binding of compound 11a with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

Subjects:

PLB is a target gene of miRNA 221. by Hongyu Li (1332669)

Subjects:

Withdrawal of Type I JAKinibs increased STAT phosphorylation, a phenomenon present but markedly lower in Type II JAKinibs. by Ilya Gurevic (1326786)

“…(A) pJAK2 peaked at time zero after exposure to baricitinib and ruxolitinib and then decreases. …”

The contributions of amino acids around 10 Å of the ligand to the binding free energy. by Ahmed A. Gaber (13302308)

Subjects:

Chronic colitis induces marked changes in protein expression in the adult heart and blood. by Yanbo Tang (11457519)

“…<p>(A) Expression levels of proteins indicated in the tissue lysates of myocardium were significantly altered by DSS-induced chronic colitis. …”

Binding of compound 12b with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

Subjects:

The proportion of ALDH+ cells progressively increases while CGA+ cells markedly decreases in <i>APC</i>-mutant colon tissues from FAP patients. by Tao Zhang (43681)

“…In contrast, in <i>APC</i>-mutant tissues from FAP patients, the proportion of ALDH+ cells progressively increases while CGA+ cells markedly decreases. Crypt cell levels are indicated that range from crypt bottom (level 1) to crypt top (level ~82). …”

Increased phosphorylation of MARK2 occurs in the affected tissues of a mutant SOD1-induced ALS mouse model. by Yu-Ning Lu (10291271)

“…Immunohistochemical analyses of phosphorylated MARK2 in the brain cortex (<b>C</b>), midbrain (<b>D</b>), and striatum (<b>E</b>) from symptomatic SOD1^G93A transgenic mice and NTg controls. …”

Results obtained following a decrease in laser intensity by rotation of the Collison nebulizer. by Elliott Donghyun Kim (19469973)

“…<p>Results obtained following a decrease in laser intensity by rotation of the Collison nebulizer.…”

Binding of compound 16 with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

Subjects:

Binding of amsacrine with DNA-Topo II complex. by Ahmed A. Gaber (13302308)

Subjects:

The center of mass distances between the protein-DNA complex and the ligand (Blue line), and the protein and DNA (red line). by Ahmed A. Gaber (13302308)

Subjects:

Fig 12 - by Ahmed A. Gaber (13302308)

Subjects: